Li et al. [98] demonstrated that Bmi-1 was overexpressed in 93.9% of glioma samples from 297 patients evaluated and that this expression was inversely correlated with the survival time of patients and positively correlated with disease prognosis. Here, BMI1 is linked to glioma.